Pneumonia
📧 Sign up to get email alerts when something new happens for Pneumonia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-08-18Clinical Trial Update: Double-Blind, Randomized, Placebo-Controlled, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 Subjects [Phase 3]
A Phase 3 randomized, double-blind, placebo-controlled trial evaluating fostamatinib for COVID-19 has completed enrollment and study status.
-
CLINICAL_TRIALS trial_result · 2023-08-14Clinical Trial Update: Best Supportive Care With or Without Low Dose Whole Lung Radiation Therapy for the Treatment of COVID-19 [Phase 3]
A Phase 3 clinical trial comparing best supportive care with or without low-dose whole lung radiation therapy for COVID-19-related pneumonia…
-
CLINICAL_TRIALS trial_result · 2023-06-26Clinical Trial Update: A Study to Evaluate Efficacy and Safety of PTC299 (Emvododstat) in Hospitalized Participants With Coronavirus (COVID-19) [Phase 2, Phase 3]
A Phase 2/Phase 3 trial evaluating emvododstat (PTC299) for hospitalized COVID-19 pneumonia has been terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2023-05-08Clinical Trial Update: Study to Compare the Efficacy of Pristinamycin (Pyostacine ®) Versus Amoxicillin in the Treatment of Acute Community Acquired Pneumonia [Phase 4]
A Phase 4 trial comparing pristinamycin (Pyostacine) to amoxicillin for acute community-acquired pneumonia was terminated.
-
CLINICAL_TRIALS trial_result · 2023-04-27Clinical Trial Update: Effects of Oral Care With Glutamine on Oral Health, Oral Flora and Incidence of Pneumonia After Neurosurgery With Microbiome Analysis [Phase 4]
Phase 4 trial update examining oral glutamine care on oral health, microbiome, and pneumonia incidence after neurosurgery.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2023-03-14Clinical Trial Update: Research on the Treatment of Severe Community-acquired Pneumonia in Children [Phase 4]
Phase 4 clinical trial update on treatment for severe pneumonia in children.
-
FDA approval · 2022-11-02FDA Approved: AMOXICILLIN — Supplemental Application (USAntibiotics, LLC)
FDA approved a supplemental application for Amoxicillin submitted by USAntibiotics, LLC.
-
FDA approval · 2022-08-18FDA Approved: MEROPENEM — Original Application (BROOKS STERISCIENCE LIMITED)
FDA approves Brooks SterisScience Limited's original application for generic meropenem (Meropenem) for multiple susceptible bacterial infect…
-
CLINICAL_TRIALS trial_result · 2022-08-16Clinical Trial Update: Anakinra in the Management of COVID-19 Infection [Phase 2, Phase 3]
A completed Phase 2/3 clinical trial evaluating anakinra for COVID-19–related pneumonia and cytokine release syndrome.
-
CLINICAL_TRIALS trial_result · 2022-08-02Clinical Trial Update: A Phase 1/Phase 2 Study of Polyvalent Pneumococcal Conjugate Vaccine (V116) in Adults (V116-001) [Phase 1, Phase 2]
A Phase 1/Phase 2 trial evaluating the polyvalent pneumococcal conjugate vaccine V116 in adults has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2022-07-25Clinical Trial Update: Study on Combined Vaccination With Quadrivalent Influenza Vaccine and 23-valent Pneumococcal Polysaccharide Vaccine [Phase 4]
A Phase 4 trial update on combining quadrivalent influenza vaccine with the 23-valent pneumococcal polysaccharide vaccine for influenza and …
-
CLINICAL_TRIALS trial_result · 2022-06-06Clinical Trial Update: Study of M5049 in Participants With COVID-19 Pneumonia (ANEMONE) [Phase 2]
Phase 2 clinical trial Update for M5049 in participants with COVID-19 pneumonia (ANEMONE) has completed with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-05-25Clinical Trial Update: Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19 [Phase 1, Phase 2]
Clinical trial update for CYNK-001 natural killer cell infusions in adults with COVID-19, spanning Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2022-04-26Clinical Trial Update: Evaluation of a Disposable Flexible Bronchoscope, aScope IV [NA]
Clinical trial update for a disposable flexible bronchoscope (aScope IV) has been terminated; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-04-20Clinical Trial Update: Study of 10-valent Pneumococcal Conjugate Vaccine (Pneumosil) Administered in a 2+1 Schedule to Healthy Infants [Phase 3]
Phase 3 trial of Pneumosil given in a 2+1 schedule to healthy infants; completed with posted results in 2022.
-
CLINICAL_TRIALS trial_result · 2022-04-19Clinical Trial Update: COVID-19 Convalescent Plasma for the Treatment of Hospitalized Patients With Pneumonia Caused by SARS-CoV-2. [Phase 1]
Phase 1 clinical trial update for COVID-19 convalescent plasma in hospitalized pneumonia due to SARS-CoV-2; study completed with results pos…
-
CLINICAL_TRIALS trial_result · 2022-04-01Clinical Trial Update: Convalescent Plasma for Treatment of COVID-19 Patients With Pneumonia [Phase 2]
Phase 2 trial update on convalescent plasma for treating COVID-19 pneumonia; study completed and results posted.
-
CLINICAL_TRIALS trial_result · 2022-03-25Clinical Trial Update: Study to Evaluate the Safety and Efficacy of XAV-19 in Patients With COVID-19 Induced Moderate Pneumonia [Phase 2]
Phase 2 trial evaluating safety and efficacy of XAV-19 in patients with COVID-19–related moderate pneumonia has completed.
-
FDA approval · 2022-03-18FDA Approved: CEFEPIME HYDROCHLORIDE AND DEXTROSE — Supplemental Application (B. Braun Medical Inc.)
FDA approved a supplemental application for Cefepime hydrochloride and dextrose from B. Braun Medical Inc.
-
CLINICAL_TRIALS trial_result · 2022-03-17Clinical Trial Update: Reparixin in COVID-19 Pneumonia - Efficacy and Safety [Phase 2, Phase 3]
Clinical trial update for Reparixin in severe pneumonia (COVID-19) shows termination with posted results; phases 2 and 3 were conducted but …
-
FDA approval · 2022-02-23FDA Approved: LINEZOLID — Supplemental Application (Ascend Laboratories, LLC)
FDA approved a supplemental application for LINEZOLID by Ascend Laboratories, LLC. The action approves changes to the product's labeling for…
-
FDA approval · 2022-02-17FDA Approved: LINEZOLID — Supplemental Application (Hospira, Inc.)
FDA approved a supplemental application for Linezolid submitted by Hospira, Inc. under NDA206473.
-
CLINICAL_TRIALS trial_result · 2022-02-11Clinical Trial Update: Zinc Pneumonia Outpatient Trial in Children < 2 Years [Phase 3]
Phase 3 trial update for zinc treatment in outpatient children under 2 with pneumonia; study completed.
-
CLINICAL_TRIALS trial_result · 2022-02-01Clinical Trial Update: Effects of Recombinant Human Thrombopoietin on Platelet Levels in ICU Patients [Phase 4]
Phase 4 trial evaluating recombinant human thrombopoietin for increasing platelet levels in ICU patients with pneumonia and thrombocytopenia…
-
CLINICAL_TRIALS trial_result · 2021-12-07Clinical Trial Update: Genomics and Epigenomics of the Elderly Response to Pneumococcal Vaccines [Phase 4]
Phase 4 clinical trial evaluating genomics and epigenomics of the elderly response to pneumococcal vaccines; results have been posted.